SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

3164 (3164) News

Follow 3164 (3164) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 3164 Asset market Sector Markets 90 days 3 Updated Nov 10, 2026, 06:46 AM UTC Open live news feed
M Genmont Biotech Reports Third-Quarter Net Profit of NT$14.8 Million Genmont Biotech reported third-quarter net profit of NT$14.8 million, compared with NT$22.3 million a year earlier. Revenue was NT$103.432 million versus NT$88.902 million. EQUITY | Nov 10, 2026, 07:57 AM UTC M Genmont Biotech Reports October Revenue of NT$35.395 Million October revenue was NT$35,395,000, compared with NT$36,895,000 a year earlier. January–October revenue totaled NT$331,329,000, versus NT$337,420,000 in 2025. EARNINGS | Nov 10, 2026, 06:46 AM UTC M Genmont Biotech reports Sep revenue NT$45.6M vs NT$31.0M Genmont Biotech Inc. reported September revenue of NT$45.578M versus NT$31.026M, and Jan-Sep revenue of NT$295.934M versus NT$300.525M, per Taiwan Stock Exchange figures. EARNINGS | Oct 08, 2026, 06:33 AM UTC L Genmont Biotech reports Aug revenue of NT$30.3M vs NT$26.2M Genmont Biotech Inc. reported 2026 revenue of NT$30,302,000 versus NT$26,236,000 in 2025. Jan-Aug revenue was NT$250,356,000 versus NT$269,499,000, per the Taiwan Stock Exchange. EQUITY | Sep 08, 2026, 06:57 AM UTC